Frontlight ResearchEarly access
Trial site
San Fernando Valley Health Institute
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity7 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Recruiting5 trials
- Completed3 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Amgen3 trials
- Pfizer3 trials
- HighTide Therapeutics (Hong Kong) Limited1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
Active, not recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Type 2 diabetes3 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026